University of California at Los Angeles — Los Angeles, California

Public research footprint of University of California at Los Angeles, compiled from the ClinicalTrials.gov public registry.

142

Registered studies

Active

Recruiting now

101

Completed

Stopped or withdrawn

Most-studied conditions

Prostate Cancer · Stroke · Ann Arbor Stage I Childhood Hodgkin Lymphoma · Locally Advanced Head and Neck Carcinoma

Recently updated registry entries

NCT05115760 — Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement… (Active Not Recruiting)
NCT06810778 — Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell… (Recruiting)
NCT04722822 — The HPV 9-10 Trial: Early Initiation of HPV Vaccination (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California at Los Angeles?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.